(Q46717613)

English

Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation

scientific article published on 5 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

0 references

Plasmodium falciparum

1 reference

based on heuristic

inferred from title

7

object named as

Peter Ouma

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Laurence Slutsker

12

object named as

Laurence Slutsker

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

Venkatachalam Udhayakumar

11

object named as

Venkatachalam Udhayakumar

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

9

object named as

John Vulule

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

1

object named as

Mary J Hamel

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Andrea M McCollum

4

object named as

Andrea McCollum

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

author name string

Amanda Poe

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Peter Bloland

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Zhiyong Zhou

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Ya Ping Shi

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Kephas Otieno

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Ananias Escalante

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

publication date

5 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

102

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

338-345

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Plasmodium falciparum sporozoite and entomological inoculation rates at the Ahero rice irrigation scheme and the Miwani sugar-belt in western Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TRSTMH.2008.01.018

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18321547

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46717613&oldid=2128021997"